X4 Pharmaceuticals Inc (XFOR): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 11,6 US Dollar | 5 | 0 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 99.146.743 | 7,57 | 7,58 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name X4 Pharmaceuticals Inc
Mitarbeiter 45
Handelsplatz NASDAQ
Ticker Symbol XFOR
IPO Datum 2017-11-16
Adresse 61 North Beacon Street, Boston, MA, United States, 02134
Webseite https://www.x4pharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Adam R. Craig M.B.A., M.D., Ph.D. | Executive Chair |
| 2 | Mr. John P. Volpone M.B.A. | President & COO |
| 3 | Mr. David H. Kirske | CFO, Treasurer & Corporate Secretary |
| 4 | Dr. Richard Peters M.D., Ph.D. | Founder |
| 5 | Dr. Renato T. Skerlj Ph.D. | Founder |
| 6 | Dr. Keith T. Flaherty M.D. | Founder & Member of Corporate Advisory Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Morgan Stanley - Brokerage Accounts | 9,54% | 31,70 Mio. USD |
| 2 | FMR Inc | 8,39% | 27,88 Mio. USD |
| 3 | Bain Capital Life Sciences Investors, LLC | 8,04% | 26,69 Mio. USD |
| 4 | Perceptive Advisors LLC | 8,00% | 26,58 Mio. USD |
| 5 | Kalehua Capital Management LLC | 7,51% | 24,94 Mio. USD |
| 6 | Saturn V Capital Management LLC | 7,03% | 23,36 Mio. USD |
| 7 | Empery Asset Management, LP | 6,99% | 23,22 Mio. USD |
| 8 | Deep Track Capital, LP | 5,93% | 19,69 Mio. USD |
| 9 | BlackRock Inc | 5,60% | 18,61 Mio. USD |
| 10 | Nantahala Capital Management, LLC | 4,94% | 16,41 Mio. USD |
| 11 | Vanguard Capital Management, LLC | 3,75% | 12,45 Mio. USD |
| 12 | Rosalind Advisors, Inc. | 3,24% | 10,77 Mio. USD |
| 13 | BRAIDWELL LP | 2,95% | 9,79 Mio. USD |
| 14 | Blackstone Inc | 2,71% | 8,98 Mio. USD |
| 15 | Trails Edge Capital Partners, LP | 2,59% | 8,61 Mio. USD |
| 16 | Bvf Inc | 2,25% | 7,48 Mio. USD |
| 17 | Geode Capital Management, LLC | 2,12% | 7,03 Mio. USD |
| 18 | VR Adviser, LLC | 1,95% | 6,48 Mio. USD |
| 19 | Samsara BioCapital, LLC | 1,41% | 4,68 Mio. USD |
| 20 | State Street Corp | 1,31% | 4,34 Mio. USD |